» Articles » PMID: 34540271

Comparison Between Shear Wave Elastography and Serological Findings for the Evaluation of Fibrosis in Chronic Liver Disease

Overview
Journal J Ultrason
Date 2021 Sep 20
PMID 34540271
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we sought to examine the optimal cutoff values for predicting different stages of liver fibrosis, and to determine the level of agreement between shear wave elastography and aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 index (FIB-4) scores in patients with chronic liver disease. A descriptive, cross-sectional study was performed at the Radiology Department of Shaukat Khanum Memorial Hospital Lahore from 1 Jun 2019 until 1 June 2020. FIB-4 and APRI scores were determined by the following formula: FIB-4 = (age × AST) ÷ (platelet count × (√ (ALT)) and APRI = (AST÷AST upper limit of normal) ÷ platelet × 100. Data was analyzed with the help of SPSS version 24.0 and Microsoft Excel 2013. Eighty individuals were conveniently selected, of which 62.5% were men and 37.5% were women. The mean age of the subjects was 43.47 SD ± 13.85 years. APRI and FIB-4 scores predicted F4 patients using the cutoff values of 0.47 (Sn. 72%, Sp. 70%) and 1.27 (Sn. 78%, Sp. 73%), respectively. The cutoff values of 0.46 for APRI and 1.27 for FIB-4 predicted F3-F4 patients (Sn. 74% and 77%; Sp. 76% and 76%), respectively. To predict F1-F4 compared to F0, the cutoff value was 0.34 (Sn. 68%, Sp. 75%) for APRI, while the cutoff value for FIB was 0.87 (Sn. 72%, Sp. 75%). The findings suggest that FIB-4 shows better diagnostic accuracy than APRI. This study provides optimal cutoff values for different groups of fibrosis patients for both serum markers. Also, the diagnostic accuracy of FIB-4 for predicting liver fibrosis was found to be superior to APRI in all disease stages.

Citing Articles

Influence of elevated liver enzyme level on 30-day mortality rates in patients undergoing nonemergency orthopedic surgery.

Liao T, Lee Y, Chang C, Liao A, Lai Y, Liu C Perioper Med (Lond). 2024; 13(1):35.

PMID: 38711142 PMC: 11071270. DOI: 10.1186/s13741-024-00395-7.

References
1.
Yen Y, Kuo F, Kee K, Chang K, Tsai M, Hu T . APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level. PLoS One. 2018; 13(6):e0199760. PMC: 6023204. DOI: 10.1371/journal.pone.0199760. View

2.
Kamimoto Y, Horiuchi S, Tanase S, Morino Y . Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology. 1985; 5(3):367-75. DOI: 10.1002/hep.1840050305. View

3.
Spengler E, Loomba R . Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Mayo Clin Proc. 2015; 90(9):1233-46. PMC: 4567478. DOI: 10.1016/j.mayocp.2015.06.013. View

4.
Singh S, Venkatesh S, Loomba R, Wang Z, Sirlin C, Chen J . Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol. 2015; 26(5):1431-40. PMC: 5051267. DOI: 10.1007/s00330-015-3949-z. View

5.
Chou R, Wasson N . Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review. Ann Intern Med. 2013; 158(11):807-20. DOI: 10.7326/0003-4819-158-11-201306040-00005. View